Cedar Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Cedar Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-309	Closed	-$44K	–	376
2021 Q3	$44K	Hold	309	–	–	0.02%	168
2021 Q2	$48K	Hold	309	–	–	0.02%	174
2021 Q1	$48K	Hold	309	–	–	0.02%	156
2020 Q4	$46K	Hold	309	–	–	0.02%	143
2020 Q3	$41K	Hold	309	–	–	0.03%	138
2020 Q2	$36K	Buy	+309	New	+$35.6K	0.02%	141

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cedar Wealth Management's ZBH Position: Q4 2021 in Review

Cedar Wealth Management sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 309 shares — an estimated $44K sold.

Cedar Wealth Management first reported a position in ZBH in Q2 2020 and held it in 6 quarters. The position peaked at $48K in Q2 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Cedar Wealth Management reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Cedar Wealth Management sold 309 Zimmer Biomet shares in Q4 2021, an estimated $44K.
Cedar Wealth Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 6 quarters.
Cedar Wealth Management's Zimmer Biomet position peaked at $48K in Q2 2021.
998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Cedar Wealth Management's 13F filing for Q4 2021, filed 11 Feb 2022.